Last updated on June 2017

Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients


Brief description of study

To characterize the pharmacokinetics (PK) of naloxegol after single oral dose and through population PK in paediatric patients with opioid induced constipation (OIC).

Clinical Study Identifier: NCT02099591

Contact Investigators or Research Sites near you

Start Over